Section Arrow
NVS.NYSE
- Novartis AG
Quotes are at least 15-min delayed:2026/03/10 00:31 EDT
Regular Hours
Last
 162.79
+2.67 (+1.67%)
Day High 
163.08 
Prev. Close
160.12 
1-M High
170.46 
Volume 
1.75M 
Bid
160.2
Ask
162.76
Day Low
159.22 
Open
159.52 
1-M Low
155.94 
Market Cap 
305.53B 
Currency 美元 
P/E 22.39 
%Yield 5.39 
10-SMA 165.01 
20-SMA 163.21 
50-SMA 151.87 
52-W High 170.46 
52-W Low 97.715 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
7.15/10.03
Enterprise Value
335.13B
Balance Sheet
Book Value Per Share
24.18
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
56.67B
Operating Revenue Per Share
28.41
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDCXMedicus Pharma Ltd0.52+0.1348+34.99%-- 
PFEPfizer26.81-0.24-0.89%19.84PE
NVONovo-Nordisk A/S39.78+1.2+3.11%10.75PE
BMYBristol-Myers Squibb Co60.63+0.34+0.56%17.41PE
MRKMerck & Co117.11+1.32+1.14%15.9PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includesoff-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.